Courtney T. Thorne's practice focuses on the representation of public companies and investment banks in the life sciences industry, with an emphasis on capital raising, public company counseling, foreign private issuer matters and securities law compliance. In addition to a robust US practice, she has substantial expertise advising non-US companies (known as foreign private issuers or FPIs) seeking to access the US capital markets or to list on a US securities exchange. Over the past five years, Courtney has advised 35+ IPOs and follow-on offerings, with an aggregate value of over $3.1 billion.
Download full bio